v3.22.2.2
General (Details)
 3 Months Ended 9 Months Ended 12 Months Ended
Jan. 14, 2022
USD ($)
Sep. 30, 2022
USD ($)
item
location
Center
$ / shares
Dec. 31, 2021
USD ($)
item
$ / shares
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
item
location
Center
segment
$ / shares
Sep. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
item
$ / shares
Oct. 24, 2022
$ / shares
shares
Oct. 18, 2022
location
Jan. 31, 2022
USD ($)
Common stock, par value | $ / shares   $ 0.01 $ 0.01   $ 0.01   $ 0.01 $ 0.01    
Number of operating segments | segment         4          
Total revenue, net   $ 10,736,000   $ 26,767,000 $ 48,381,000 $ 44,371,000        
Cash and cash equivalents   49,429,000 $ 105,506,000   49,429,000   $ 105,506,000      
Total current assets   55,181,000 108,979,000   55,181,000   108,979,000      
Total current liabilities   10,984,000 19,827,000   10,984,000   19,827,000      
Working capital   44,197,000 $ 89,152,000   44,197,000   $ 89,152,000      
Issuance of Common Stock on acquisition of gcg Connect, LLC, d/b/a HyperPointe         906,000          
Total operating loss   (7,654,000)   7,057,000 (17,872,000) 1,935,000        
Net loss   (7,179,000)   5,597,000 (19,380,000) 74,000        
Other                    
Total revenue, net   4,000     4,000 14,000        
Travel, health and wellness brand, treat                    
Net loss   $ 1,290,000     $ 4,049,000          
XpresSpa                    
Number of hours worked per day during post-pandemic time | item   8     8          
Number of hours worked pre-pandemic time | item   16     16          
Total operating loss   $ (2,508,000)   (1,595,000) $ (8,921,000) (4,828,000)        
XpresSpa | United States                    
Number of operating locations | location   20     20          
Number of location reopenings planned | location         2          
XpresSpa | Non-US                    
Number of airport locations | location   8     8          
XpresTest                    
Number of operating locations | location   8     8          
Number of non performing wellness centers | Center   5     5          
Number of wellness centers assimilated to treat segment | Center   2     2          
Number of airports | item   8     8          
Impairment of related long-lived assets   $ 1,040,000                
Total operating loss   (1,692,000)   12,015,000 $ 2,576,000 14,597,000        
XpresTest | Bio-surveillance Monitoring | United States                    
Number of airport locations | item     4       4      
Treat                    
Total operating loss   (1,282,000)   $ (2,305,000) (4,038,000) $ (4,115,000)        
HyperPointe                    
Payments to acquire business $ 7,121,000                  
Issuance of Common Stock on acquisition of gcg Connect, LLC, d/b/a HyperPointe 906,000                  
Settlement of intercompany accounts payable 770,000                  
Fair value of potential earnout $ 0 $ 0     $ 0          
Timeframe within which potential additional earnout payments to be made for Business acquisition 3 years                  
HyperPointe | Maximum [Member]                    
Business acquisition, potential additional earnout payments $ 7,500,000                  
Orlando International Airport | XpresTest                    
Number of operating locations | location   1     1          
Austin-Bergstrom International Airport | XpresSpa                    
Number of Franchise Locations Sold | location         2          
Dubai International Airport | Non-US                    
Number of operating locations | location   3     3          
Schiphol Amsterdam Airport | Non-US                    
Number of operating locations | location   3     3          
Istanbul Airport | Non-US                    
Number of operating locations | location   2     2          
Number of location reopenings planned | location         5          
Number Of Location Expected to be Open | location   2     2          
Subsequent event | Istanbul Airport | Non-US                    
Number of location opened | location                 3  
CDC Program Options and Public Health Services [Member] | XpresTest                    
Unrecognized revenue   $ 16,000     $ 16,000          
Total revenue, net   916,000                
CDC Program Options and Public Health Services [Member] | XpresTest | Passenger and Aircraft Wastewater Sample Collection                    
Contract with customer, liability, current   6,761,000     6,761,000          
CDC Program Options and Public Health Services [Member] | XpresTest | Traveler Enrollment Initiatives                    
Contract with customer, liability, current   570,000     570,000          
CDC Program Options and Public Health Services [Member] | XpresTest | Minimum [Member]                    
Unrecognized revenue   61,000     61,000          
Centers for Disease Control and Prevention [Member] | XpresTest                    
Revenue contract amount             $ 2,001,000      
Unrecognized revenue   $ 5,534,000     5,534,000         $ 5,534,000
Revenue recognized     $ 1,368,000   $ 4,166,000          
Series A Convertible Preferred stock                    
Preferred stock, par value | $ / shares               $ 0.01    
Preferred stock, authorized | shares               6,968    
Preferred stock, outstanding | shares               0    
Series D Convertible Preferred Stock                    
Preferred stock, par value | $ / shares               $ 0.01    
Preferred stock, authorized | shares               500,000    
Preferred stock, outstanding | shares               0    
Series E Convertible Preferred Stock.                    
Preferred stock, par value | $ / shares               $ 0.01    
Preferred stock, authorized | shares               2,397,060    
Preferred stock, outstanding | shares               0    
Series F Convertible Preferred Stock.                    
Preferred stock, par value | $ / shares               $ 0.01    
Preferred stock, authorized | shares               9,000    
Preferred stock, outstanding | shares               0